FundedIQ
Biotechnology

BBOT: Funding, Investors & Team (Oct 2026)

BBOT is a biopharmaceutical company in the clinical stage that is developing a new pipeline of small molecule drugs to treat cancers caused by RAS and PI3Kα mutations. The company aims to enhance the survival rates of patients with these types of cancer, which are driven by the most common oncogenes in human tumors. Visit bridgebiooncology.com for further details.

bridgebiooncology.com LinkedIn Palo Alto, United States 51-100 employees
Biopharma Therapeutics
Total raised
$261M
Rounds
1
Latest
Undisclosed round
Aug 2025

BBOT has raised $261M across 1 funding round on record, the most recent an undisclosed round of $261M announced in Aug 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

BBOT Company Profile and Key Stats

Total funding raised
$261M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$261M in Aug 2025
Employees
51-100
reported band
Headquarters
Palo Alto, United States

Latest funding round on record: Aug 2025.

BBOT Funding Rounds

Date
Round
Amount
Undisclosed round
$261M

BBOT Founders and Leadership Team

Name
Role
Contact
Eli M Wallace
Founder
Locked

Contact details for the BBOT team: 1 of 1 has an email address on file.

Start 14-day free trial →

BBOT Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

BBOT's latest round of $261M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like BBOT in Biotechnology and Palo Alto

Companies Similar to BBOT

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

BBOT Funding FAQs

What does BBOT do?

BBOT is a biopharmaceutical company in the clinical stage that is developing a new pipeline of small molecule drugs to treat cancers caused by RAS and PI3Kα mutations. The company aims to enhance the survival rates of patients with these types of cancer, which are driven by the most common oncogenes in human tumors. Visit bridgebiooncology.com for further details.

How much funding has BBOT raised?

BBOT has raised $261M across 1 round on record. The most recent is an undisclosed round of $261M announced in Aug 2025.

When did BBOT last raise funding?

BBOT's most recent funding round on record is an undisclosed round of $261M, announced in Aug 2025.

Who founded BBOT?

FundedIQ lists Eli M Wallace (Founder) at BBOT.

Where is BBOT headquartered?

BBOT is based in Palo Alto, California, United States.

How many employees does BBOT have?

BBOT is in the 51-100 employee band.

How does BBOT's funding compare to other Biotechnology startups?

BBOT's latest round of $261M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's BBOT Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BBOT is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.